Chromosome 22q11.2 deletion causes PERK-dependent vulnerability in dopaminergic neurons

Background: The chromosome 22q11.2 deletion is an extremely high risk genetic factor for various neuropsychiatric disorders; however, the 22q11.2 deletion-related brain pathology in humans at the cellular and molecular levels remains unclear. Methods: We generated iPS cells from healthy controls (co...

Full description

Bibliographic Details
Main Authors: Yuko Arioka, Emiko Shishido, Itaru Kushima, Toshiaki Suzuki, Ryo Saito, Atsu Aiba, Daisuke Mori, Norio Ozaki
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396420305144
id doaj-8b0b83af8f5446f787b7f3987c04c935
record_format Article
spelling doaj-8b0b83af8f5446f787b7f3987c04c9352021-01-22T04:50:08ZengElsevierEBioMedicine2352-39642021-01-0163103138Chromosome 22q11.2 deletion causes PERK-dependent vulnerability in dopaminergic neuronsYuko Arioka0Emiko Shishido1Itaru Kushima2Toshiaki Suzuki3Ryo Saito4Atsu Aiba5Daisuke Mori6Norio Ozaki7Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan; Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan; Institute for Advanced Research, Nagoya University, Nagoya, Japan; Corresponding authors.Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan; National Institute for Physiological Sciences, Okazaki, JapanDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan; Medical Genomics Center, Nagoya University Hospital, Nagoya, JapanDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, JapanLaboratory of Animal Resources, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, JapanLaboratory of Animal Resources, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, JapanDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan; Brain and Mind Research Center, Nagoya University, Nagoya, JapanDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan; Medical Genomics Center, Nagoya University Hospital, Nagoya, Japan; Brain and Mind Research Center, Nagoya University, Nagoya, Japan; Corresponding authors.Background: The chromosome 22q11.2 deletion is an extremely high risk genetic factor for various neuropsychiatric disorders; however, the 22q11.2 deletion-related brain pathology in humans at the cellular and molecular levels remains unclear. Methods: We generated iPS cells from healthy controls (control group) and patients with 22q11.2 deletion (22DS group), and differentiated them into dopaminergic neurons. Semiquantitative proteomic analysis was performed to compare the two groups. Next, we conducted molecular, cell biological and pharmacological assays. Findings: Semiquantitative proteomic analysis identified ‘protein processing in the endoplasmic reticulum (ER)’ as the most altered pathway in the 22DS group. In particular, we found a severe defect in protein kinase R-like endoplasmic reticulum kinase (PERK) expression and its activity in the 22DS group. The decreased PERK expression was also shown in the midbrain of a 22q11.2 deletion mouse model. The 22DS group showed characteristic phenotypes, including poor tolerance to ER stress, abnormal F-actin dynamics, and decrease in protein synthesis. Some of phenotypes were rescued by the pharmacological manipulation of PERK activity and phenocopied in PERK-deficient dopaminergic neurons. We lastly showed that DGCR14 was associated with reduction in PERK expression. Interpretation: Our findings led us to conclude that the 22q11.2 deletion causes various vulnerabilities in dopaminergic neurons, dependent on PERK dysfunction. Funding: This study was supported by the AMED under grant nos JP20dm0107087, JP20dm0207075, JP20ak0101113, JP20dk0307081, and JP18dm0207004h0005; the MEXT KAKENHI under grant nos. 16K19760, 19K08015, 18H04040, and 18K19511; the Uehara Memorial Foundation under grant no. 201810122; and 2019 iPS Academia Japan Grant.http://www.sciencedirect.com/science/article/pii/S235239642030514422q11.2 deletionNeuropsychiatric disordersiPS cellsDopaminergic neuronsPERK
collection DOAJ
language English
format Article
sources DOAJ
author Yuko Arioka
Emiko Shishido
Itaru Kushima
Toshiaki Suzuki
Ryo Saito
Atsu Aiba
Daisuke Mori
Norio Ozaki
spellingShingle Yuko Arioka
Emiko Shishido
Itaru Kushima
Toshiaki Suzuki
Ryo Saito
Atsu Aiba
Daisuke Mori
Norio Ozaki
Chromosome 22q11.2 deletion causes PERK-dependent vulnerability in dopaminergic neurons
EBioMedicine
22q11.2 deletion
Neuropsychiatric disorders
iPS cells
Dopaminergic neurons
PERK
author_facet Yuko Arioka
Emiko Shishido
Itaru Kushima
Toshiaki Suzuki
Ryo Saito
Atsu Aiba
Daisuke Mori
Norio Ozaki
author_sort Yuko Arioka
title Chromosome 22q11.2 deletion causes PERK-dependent vulnerability in dopaminergic neurons
title_short Chromosome 22q11.2 deletion causes PERK-dependent vulnerability in dopaminergic neurons
title_full Chromosome 22q11.2 deletion causes PERK-dependent vulnerability in dopaminergic neurons
title_fullStr Chromosome 22q11.2 deletion causes PERK-dependent vulnerability in dopaminergic neurons
title_full_unstemmed Chromosome 22q11.2 deletion causes PERK-dependent vulnerability in dopaminergic neurons
title_sort chromosome 22q11.2 deletion causes perk-dependent vulnerability in dopaminergic neurons
publisher Elsevier
series EBioMedicine
issn 2352-3964
publishDate 2021-01-01
description Background: The chromosome 22q11.2 deletion is an extremely high risk genetic factor for various neuropsychiatric disorders; however, the 22q11.2 deletion-related brain pathology in humans at the cellular and molecular levels remains unclear. Methods: We generated iPS cells from healthy controls (control group) and patients with 22q11.2 deletion (22DS group), and differentiated them into dopaminergic neurons. Semiquantitative proteomic analysis was performed to compare the two groups. Next, we conducted molecular, cell biological and pharmacological assays. Findings: Semiquantitative proteomic analysis identified ‘protein processing in the endoplasmic reticulum (ER)’ as the most altered pathway in the 22DS group. In particular, we found a severe defect in protein kinase R-like endoplasmic reticulum kinase (PERK) expression and its activity in the 22DS group. The decreased PERK expression was also shown in the midbrain of a 22q11.2 deletion mouse model. The 22DS group showed characteristic phenotypes, including poor tolerance to ER stress, abnormal F-actin dynamics, and decrease in protein synthesis. Some of phenotypes were rescued by the pharmacological manipulation of PERK activity and phenocopied in PERK-deficient dopaminergic neurons. We lastly showed that DGCR14 was associated with reduction in PERK expression. Interpretation: Our findings led us to conclude that the 22q11.2 deletion causes various vulnerabilities in dopaminergic neurons, dependent on PERK dysfunction. Funding: This study was supported by the AMED under grant nos JP20dm0107087, JP20dm0207075, JP20ak0101113, JP20dk0307081, and JP18dm0207004h0005; the MEXT KAKENHI under grant nos. 16K19760, 19K08015, 18H04040, and 18K19511; the Uehara Memorial Foundation under grant no. 201810122; and 2019 iPS Academia Japan Grant.
topic 22q11.2 deletion
Neuropsychiatric disorders
iPS cells
Dopaminergic neurons
PERK
url http://www.sciencedirect.com/science/article/pii/S2352396420305144
work_keys_str_mv AT yukoarioka chromosome22q112deletioncausesperkdependentvulnerabilityindopaminergicneurons
AT emikoshishido chromosome22q112deletioncausesperkdependentvulnerabilityindopaminergicneurons
AT itarukushima chromosome22q112deletioncausesperkdependentvulnerabilityindopaminergicneurons
AT toshiakisuzuki chromosome22q112deletioncausesperkdependentvulnerabilityindopaminergicneurons
AT ryosaito chromosome22q112deletioncausesperkdependentvulnerabilityindopaminergicneurons
AT atsuaiba chromosome22q112deletioncausesperkdependentvulnerabilityindopaminergicneurons
AT daisukemori chromosome22q112deletioncausesperkdependentvulnerabilityindopaminergicneurons
AT norioozaki chromosome22q112deletioncausesperkdependentvulnerabilityindopaminergicneurons
_version_ 1724328687907635200